PERSPECTIVE THERAPEUTICS INC. reports a Return on Equity (ROE) of -31.99%.

What is CATX's dividend yield?

PERSPECTIVE THERAPEUTICS INC. offers a dividend yield of 0.00%.

What is CATX's Deepscope Quality Score?

Deepscope rates CATX's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy CATX?

Deepscope's AI Timing Score for CATX is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does CATX belong to?

PERSPECTIVE THERAPEUTICS INC. is classified under the Healthcare >> Medical Devices sector on the NYSE MKT exchange.

Cổ phiếu CATX (NYSE MKT) | PERSPECTIVE THERAPEUTICS INC.

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-12 | FS: 2026-03-31)

CATX

PERSPECTIVE THERAPEUTICS INC.

US:NYSE MKT STOCK Healthcare >> Medical Devices News 78

USD 2.95

-0.02 (-0.67%) Day Change

Watchlist Portfolio Compare Chart

0.01

D/E

-32.0%

ROE

-27.1%

ROA

0.00%

Div Yield

PERSPECTIVE THERAPEUTICS INC.
TYPE: STOCK
MARKET: NYSE MKT

Compare Watchlist Myport

USD 2.95 Price -0.02 (-0.67%) Day Change	NEWS SCORE: 78

CATX Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 31) và Thời điểm mua ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
ROA quá thấp so với ROE
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Không tốt , ...

Yếu tố Chất lượng

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	78
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	2.95
PBV / Sector	0.97 / 7.44 GREAT
Earning Per Share	-0.97

PE / Sector	N/A / 29.54
PEG or PE/Growth / Sector	N/A / 0.40
Average 1M Daily Value	4.37 M GREAT
Average 1W Daily Value	3.45 M GREAT

Yếu tố Kỹ thuật

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

43%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-17,982.69 / 20.12
NPM Average (%) / Sector	-8,274.42 / -15.01
NPM Change Average (%) / Sector	N/A / 2.65
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-27.05 / 11.02
ROA Average (%) / Sector	-32.34 / -0.05
ROA Change Average (%) / Sector	18.32 / 7.12 GOOD
ROE (%) / Sector	-31.99 / 42.27
ROE Average (%) / Sector	-39.56 / 24.22
ROE Change Average (%) / Sector	30.34 / 0.94 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.47
Dividend Average (%) / Sector	N/A / 1.88
Dividend Change Average (%) / Sector	N/A / 5.95

Chi tiết đăng ký

Analyze Date	2026-06-13 11:14:01
Symbol	CATX
Name	PERSPECTIVE THERAPEUTICS INC.
Sector	Healthcare >> Medical Devices
Market	NYSE MKT
Listed Shares	114.05 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	338.72 / 18,290.40

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 2401 Elliott Avenue, Seattle, WA, United States, 98121

Phone: 206 676 0900

Website: https://www.perspectivetherapeutics.com

Employees: 163

Sector: Healthcare >> Medical Devices

Description: Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. It discovers and develops its initial drug candidate VMT-a-NET that is in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)-expressing neuroendocrine tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a beta emitting therapy; VMT01, which is in Phase 1/2a clinical trials for second-line or later treatment of patients with progressive melanocortin 1 receptor (MC1R) positive metastatic melanoma; and PSV359, a targeted alpha therapy targeting fibroblast activation protein alpha. The company also develops Pluvicto, a betaemitting radioligand therapy to treat progressive prostate-specific membrane antigen (PSMA) positive metastatic castration-resistant prostate cancer. It has a clinical trial collaboration agreement with Bristol Myers Squibb to evaluate the safety and tolerability of [212Pb] VMT01 in combination with nivolumab in patients with histologically confirmed melanoma and positive MC1R imaging scans. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 2004 and is headquartered in Seattle, Washington.